NO20002967D0 - Uretaner avledet fra azacycloalkaner, tio og ditioanaloger, samt fremstilling og anvendelse derav som 2,3 epoksysqualen- lanesterol cyclase inhibitor - Google Patents

Uretaner avledet fra azacycloalkaner, tio og ditioanaloger, samt fremstilling og anvendelse derav som 2,3 epoksysqualen- lanesterol cyclase inhibitor

Info

Publication number
NO20002967D0
NO20002967D0 NO20002967A NO20002967A NO20002967D0 NO 20002967 D0 NO20002967 D0 NO 20002967D0 NO 20002967 A NO20002967 A NO 20002967A NO 20002967 A NO20002967 A NO 20002967A NO 20002967 D0 NO20002967 D0 NO 20002967D0
Authority
NO
Norway
Prior art keywords
uretans
lanesterol
epoxysqualene
azacycloalkanes
thio
Prior art date
Application number
NO20002967A
Other languages
English (en)
Other versions
NO20002967L (no
Inventor
Roland Maier
Peter Mueller
Gebhard Schilcher
Gebhard Adelgoss
Rudolf Hurnaus
Michael Mark
Bernhard Eisele
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20002967D0 publication Critical patent/NO20002967D0/no
Publication of NO20002967L publication Critical patent/NO20002967L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20002967A 1997-12-10 2000-06-09 Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor NO20002967L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754796A DE19754796A1 (de) 1997-12-10 1997-12-10 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
PCT/EP1998/007965 WO1999029669A1 (de) 1997-12-10 1998-12-08 Von azacycloalkanen abgeleitete urethane, ihre thio- und dithioanaloga, deren herstellung und deren verwendung als 2,3-epoxisqualen-lanosterol-cyclase inhibitoren

Publications (2)

Publication Number Publication Date
NO20002967D0 true NO20002967D0 (no) 2000-06-09
NO20002967L NO20002967L (no) 2000-08-09

Family

ID=7851381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002967A NO20002967L (no) 1997-12-10 2000-06-09 Uretaner avledet fra azacycloalkaner, tio og ditio-analoger, samt anvendelse og fremstilling av 2,3 eposkysqualen- lanesterolcyclaseinhibitor

Country Status (27)

Country Link
EP (1) EP1060162B1 (no)
JP (1) JP3418688B2 (no)
KR (1) KR20010032977A (no)
CN (1) CN1281434A (no)
AR (1) AR017827A1 (no)
AT (1) ATE234816T1 (no)
AU (1) AU1759499A (no)
BG (1) BG104500A (no)
BR (1) BR9813495A (no)
CA (1) CA2309388A1 (no)
CO (1) CO5370694A1 (no)
DE (2) DE19754796A1 (no)
DK (1) DK1060162T3 (no)
EA (1) EA200000631A1 (no)
EE (1) EE200000342A (no)
ES (1) ES2190130T3 (no)
HR (1) HRP20000377A2 (no)
HU (1) HUP0100335A3 (no)
IL (1) IL135738A0 (no)
NO (1) NO20002967L (no)
PL (1) PL341060A1 (no)
PT (1) PT1060162E (no)
SK (1) SK8612000A3 (no)
TR (1) TR200001635T2 (no)
WO (1) WO1999029669A1 (no)
YU (1) YU35600A (no)
ZA (1) ZA9811262B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077654A1 (en) * 2001-01-15 2004-04-22 Bouillot Anne Marie Jeanne Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
WO2002055495A1 (en) * 2001-01-15 2002-07-18 Glaxo Group Limited Aryl piperidine derivatives as inducers of ldl-receptor expression
EP1351937A1 (en) * 2001-01-15 2003-10-15 Glaxo Group Limited Aryl piperidine derivatives as inducers of ldl-receptor expression
DE10132686A1 (de) * 2001-07-05 2003-01-16 Boehringer Ingelheim Pharma Heteroarylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
JP4664634B2 (ja) * 2003-09-05 2011-04-06 富山化学工業株式会社 新規なベンズアミジン誘導体またはその塩

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04312572A (ja) * 1991-04-12 1992-11-04 Takeda Chem Ind Ltd 環状アミン化合物
DE4407136A1 (de) * 1994-03-04 1995-09-07 Thomae Gmbh Dr K Aroyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4407138A1 (de) * 1994-03-04 1995-09-07 Thomae Gmbh Dr K Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
SK8612000A3 (en) 2000-11-07
AU1759499A (en) 1999-06-28
DE59807591D1 (de) 2003-04-24
JP3418688B2 (ja) 2003-06-23
PL341060A1 (en) 2001-03-26
TR200001635T2 (tr) 2000-11-21
HUP0100335A3 (en) 2001-11-28
CO5370694A1 (es) 2004-02-27
WO1999029669A1 (de) 1999-06-17
DE19754796A1 (de) 1999-06-17
NO20002967L (no) 2000-08-09
EP1060162B1 (de) 2003-03-19
ES2190130T3 (es) 2003-07-16
PT1060162E (pt) 2003-08-29
ATE234816T1 (de) 2003-04-15
HRP20000377A2 (en) 2000-12-31
JP2001525397A (ja) 2001-12-11
ZA9811262B (en) 2000-06-09
KR20010032977A (ko) 2001-04-25
YU35600A (sh) 2002-09-19
EE200000342A (et) 2001-08-15
EA200000631A1 (ru) 2000-12-25
IL135738A0 (en) 2001-05-20
BG104500A (bg) 2001-03-30
CA2309388A1 (en) 1999-06-17
CN1281434A (zh) 2001-01-24
BR9813495A (pt) 2000-10-10
HUP0100335A2 (hu) 2001-07-30
AR017827A1 (es) 2001-10-24
DK1060162T3 (da) 2003-07-14
EP1060162A1 (de) 2000-12-20

Similar Documents

Publication Publication Date Title
DK0832082T3 (da) N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister
IS5744A (is) Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
FI956228L (fi) Sisäänhengitykseen tarkoitettuja koostumuksia
DK1028961T3 (da) Pleuromutilinderivater som antimikrobielle midler
DE69835557D1 (de) Wässrige Tintenzusammensetzungen
NO994906L (no) GnRH antagonister som er modifisert i stillinger 5 og 6
DK1015434T3 (da) Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid
DK0609734T3 (da) Substituerede triazolinoner samt deres anvendelse som herbicider
PT946100E (pt) Composicoes herbicidas contendo n-¬(4,6-dimetoxipirimidin-2-il)aminocarbonil|-5-metilsulfonamidometil-2-alcoxicarbonilbenzenossulfonamidas
NO996115L (no) Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister
ATE212635T1 (de) 1,3,8-triazaspiro(4,5)decan-4-on-derivate
DE69812371D1 (de) Phenyllacrylsäurederivate enthaltende fungizide kombinationen
NO20003105L (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
FI972306A7 (fi) Substituoituja 2-aryylikarbonyylioksimetyyli-1,2,5-tiadiatsolidin -3- oni-1,1-dioksidi-johdannaisia ja niitä sisältäviä koostumuksia ja mene telmiä niiden käyttämiseksi
NO20002967D0 (no) Uretaner avledet fra azacycloalkaner, tio og ditioanaloger, samt fremstilling og anvendelse derav som 2,3 epoksysqualen- lanesterol cyclase inhibitor
DE69805242D1 (de) Titanaluminidlegierung
DK0906293T3 (da) Substituerede sulfonylamino(thio)carbonylforbindelser samt deres anvendelse som herbicider
FI941149L (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
NO996244D0 (no) Pyrrolidinkarboksylsyrederivater som endotelinantagonister
NO972905D0 (no) Tienoksasinon-derivater anvendelige som antivirusmidler
DE59800203D1 (de) Bohr-, Bohrschraub- oder Schlagbohrmaschine
SI1060162T1 (sl) Uretani, izvedeni iz azacikloalkanov, njihovi tio in ditio analogi, njihova priprava in njihova uporaba kot inhibitorji 2,3-epoksiskvalen-lanesterol-ciklaze
NO20005756L (no) Karboksysubstituerte karboksamidderivater som tachykininantagonister
EE200000340A (et) Uudsed uretaanid, nende tio- ja ditioanaloogid, nende soolad, neid ühendeid sisaldavad ravimid ja nende kasutamine, samuti meetod nende valmistamiseks
FI960051L (fi) Difluoristatonianalogeja

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application